The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 03, 2018

Filed:

Aug. 21, 2012
Applicants:

Eric Wang, San Diego, CA (US);

Hartmuth C. Kolb, Playa Del Rey, CA (US);

Anna Katrin Szardenings, Torrance, CA (US);

Changhui Liu, Los Angeles, CA (US);

Joseph C. Walsh, Pacific Palisades, CA (US);

Gang Chen, Rancho Palos Verdes, CA (US);

Anjana Sinha, San Diego, CA (US);

Dhanalakshmi Kasi, Los Angeles, CA (US);

Chul Yu, Los Angeles, CA (US);

Umesh B. Gangadharmath, Los Angeles, CA (US);

Wei Zhang, Los Angeles, CA (US);

Tieming Zhao, Placentia, CA (US);

Vani P. Mocharla, Los Angeles, CA (US);

Inventors:

Eric Wang, San Diego, CA (US);

Hartmuth C. Kolb, Playa Del Rey, CA (US);

Anna Katrin Szardenings, Torrance, CA (US);

Changhui Liu, Los Angeles, CA (US);

Joseph C. Walsh, Pacific Palisades, CA (US);

Gang Chen, Rancho Palos Verdes, CA (US);

Anjana Sinha, San Diego, CA (US);

Dhanalakshmi Kasi, Los Angeles, CA (US);

Chul Yu, Los Angeles, CA (US);

Umesh B. Gangadharmath, Los Angeles, CA (US);

Wei Zhang, Los Angeles, CA (US);

Tieming Zhao, Placentia, CA (US);

Vani P. Mocharla, Los Angeles, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 5/02 (2006.01); A61K 51/04 (2006.01); C07D 249/06 (2006.01); C07D 249/04 (2006.01); A61K 51/08 (2006.01); C07K 5/062 (2006.01); C07K 5/072 (2006.01); C07D 403/12 (2006.01); C07D 213/81 (2006.01); C07D 213/82 (2006.01); C07D 233/78 (2006.01); C07D 233/96 (2006.01); C07D 401/12 (2006.01); C07D 403/06 (2006.01); C07D 405/12 (2006.01); C07D 239/60 (2006.01); C07D 251/30 (2006.01); C07D 263/34 (2006.01); C07D 207/16 (2006.01); C07D 277/56 (2006.01); C07D 209/48 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 5/0215 (2013.01); A61K 51/0453 (2013.01); A61K 51/088 (2013.01); C07D 207/16 (2013.01); C07D 209/48 (2013.01); C07D 213/81 (2013.01); C07D 213/82 (2013.01); C07D 233/78 (2013.01); C07D 233/96 (2013.01); C07D 239/60 (2013.01); C07D 249/04 (2013.01); C07D 249/06 (2013.01); C07D 251/30 (2013.01); C07D 263/34 (2013.01); C07D 277/56 (2013.01); C07D 401/12 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07K 5/06026 (2013.01); C07K 5/06113 (2013.01); A61K 38/00 (2013.01);
Abstract

Compounds for targeting and agents for imaging, Prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.


Find Patent Forward Citations

Loading…